Women who suffer from severe follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiency now have a treatment they can try in the form of the Pervogeris®️ Pen by Merck. The Indian arm of the company launched this ground-breaking product in Mumbai on August 9.

Women with an improper ovulation cycle because of an FSH-LH deficiency can use this pen, upon prescription by an IVF specialist, to get relief from the problem. As many as 27.5 million Indian couples grapple with infertility, and this pen is an advanced treatment option for many of them. The formulation within the pen can be self-administered for infertility treatment. Pergoveris®️ Pen is the world’s first combined therapy option for recombinant gonadotropins, and is being marketed as both efficient and safe for patients to use during fertility treatment.